Company Close Updates

Vertex Pharmaceuticals Inc. stock rises Thursday, still underperforms market

Company Logo

Terrence Horan

Referenced Symbols

Shares of Vertex Pharmaceuticals Inc. VRTX, -0.66% inched 0.31% higher to $181.90 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX, -0.14% rising 1.71% to 4,438.26 and the Dow Jones Industrial Average DJIA, -0.37% rising 1.56% to 34,912.56. This was the stock's fourth consecutive day of gains. Vertex Pharmaceuticals Inc. closed $61.09 short of its 52-week high ($242.99), which the company reached on January 25th.

The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Johnson & Johnson JNJ, -0.86% rose 0.57% to $160.11, Merck & Co. Inc. MRK, -0.51% fell 0.79% to $78.33, and AbbVie Inc. ABBV, -0.91% rose 1.57% to $108.91. Trading volume (1.9 M) eclipsed its 50-day average volume of 1.6 M.

Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.